Clene Inc. Common Stock
CLNN
CLNN: Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).
moreShow CLNN Financials
Recent trades of CLNN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CLNN's directors and management
Government lobbying spending instances
-
$20,000 Jul 12, 2023 Issue: Trade (domestic/foreign) Energy/Nuclear
-
$60,000 Apr 20, 2023 Issue: Trade (domestic/foreign) Energy/Nuclear
-
$50,000 Jan 19, 2023 Issue: Trade (domestic/foreign) Energy/Nuclear
-
$50,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Energy/Nuclear
-
$50,000 Jul 18, 2022 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Energy/Nuclear
-
$50,000 Apr 20, 2022 Issue: Energy/Nuclear Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$50,000 Jan 19, 2022 Issue: Taxation/Internal Revenue Code Energy/Nuclear Trade (domestic/foreign)
-
$20,000 Oct 21, 2021 Issue: Taxation/Internal Revenue Code Energy/Nuclear Trade (domestic/foreign)
New patents grants
Federal grants, loans, and purchases
Followers on CLNN's company Twitter account
Number of mentions of CLNN in WallStreetBets Daily Discussion
Recent insights relating to CLNN
Recent picks made for CLNN stock on CNBC
ETFs with the largest estimated holdings in CLNN
Flights by private jets registered to CLNN